Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
A pill to prevent HIV? What the new iPrEx results mean for women

As women’s health advocates, there are things we can do to try to ensure that the iPrEx results lead to good outcomes for women that are not eclipsed by unintended consequences.

Published
24 November 2010
From
RHrealitycheck.org
Frequently asked questions about PreP and the iPrEX trial (link to pdf)

This FAQ looks at some of the most important questions we have about PrEP and the iPrEx trial at this time.

Published
24 November 2010
From
AVAC
CDC Statement On Results Of IPrEx Trial Examining Pre-Exposure Prophylaxis (PrEP) For HIV Prevention Among Men Who Have Sex With Men

Today the National Institutes of Health (NIH) announced results of the international iPrEx trial examining whether drugs used to treat HIV can also help prevent HIV infection...

Published
24 November 2010
From
HIV / AIDS News From Medical News Today
UNAIDS And WHO Welcome New Findings That Could Provide An Additional Tool For HIV Prevention For Men Who Have Sex With Men

The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) welcome new research published today showing that an antiretroviral drug combination, taken daily as a prophylaxis, in conjunction with use of condoms, reduces the risk of HIV infection by an average of 43.8% for HIV-negative men and transgender women who have sex with men...

Published
24 November 2010
From
HIV / AIDS News From Medical News Today
A drug against AIDS could be effective against the herpesvirus

Scientists have shown that raltegravir, the drug approved in 2007 for the treatment of AIDS that is sold by Merck under the name Isentress, cancels the function of an essential protein for the replication of one kind of herpes virus.

Published
23 September 2010
From
Science Daily
ICAAC: Study Closes Vicriviroc Story

Merck has halted development of the CCR5 inhibitor vicriviroc for treatment of HIV infection, but the drug may still have a role for pre-exposure prophylaxis or microbicide use.

Published
16 September 2010
From
MedPage Today
Novel Suppository Design for HIV Chemoprophylaxis

While the intended route of application is intravaginal, it is possible that intrarectal administration could potentially provide chemoprophylaxis for men and women.

Published
28 July 2010
From
Pharmaceutical Technology

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.